Carmel Pharma AB: the Largest Ever Published Study on the Efficacy of a Closed-System Drug Transfer Device

Published: Apr 13, 2011

GĂ–TEBORG, Sweden & COLUMBUS, Ohio--(BUSINESS WIRE)--A study published in the Journal of Oncology Pharmacy Practice shows the use of the PhaSeal System, a closed-system drug transfer device for the safe handling of hazardous drugs, significantly reduces surface contamination in hospital pharmacies when preparing the following antineoplastic drugs: cyclophosphamide, ifosfamide, and 5-fluorouracil. [1]

Back to news